Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. - Wikidata - awgldk - TriplyDB

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

http://www.wikidata.org/entity/Q37373710

about

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity Is lipid signaling through cannabinoid 2 receptors part of a protective system?The endocannabinoid system as an emerging target of pharmacotherapy Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes Activation of the peripheral endocannabinoid system in human obesity Chemical probes of endocannabinoid metabolism Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?Time-dependent vascular effects of Endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPARγ)Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders Enzymatic pathways that regulate endocannabinoid signaling in the nervous system Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol Endocannabinoids, blood pressure and the human heart.Use of pressure-volume conductance catheters in real-time cardiovascular experimentation Cardiorespiratory anomalies in mice lacking CB1 cannabinoid receptors.Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation.Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats.Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications.Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.Survival, exercise capacity, and left ventricular remodeling in a rat model of chronic mitral regurgitation: serial echocardiography and pressure-volume analysis Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity.Serum contents of endocannabinoids are correlated with blood pressure in depressed women.Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.Blood pressure regulation by endocannabinoids and their receptors Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.Cannabinoid receptors in acute and chronic complications of atherosclerosis.Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity.

P2860

Q24523292-BB2E9304-8BDE-4154-B5F6-7BE5F78B132C Q24633122-6F24ACAD-5BB5-4148-8DA5-D1605AFD7044 Q24648473-766AFCF9-805C-435F-A7F6-BCA00CBBC9BC Q24648818-47398DBC-341C-4E19-AE8E-744B25DE8F81 Q24649936-1DCB8F75-23F5-4663-8D52-DEA68CB7A0D5 Q24655297-2C130D81-BEB7-4A25-8792-21060C2AC19E Q26863202-A6353FE7-032E-4091-9EA9-1B49982887F5 Q27025612-989F5D0E-11E4-48F5-8466-952BDF19148E Q28243980-7F95C642-812C-4146-93AE-54D1764DEA81 Q28285103-8C96C1A7-BE39-4257-AE9D-379E57A3552E Q28390932-1E2D6EFA-1EA2-4708-8366-8C88C867277C Q28582727-49A8C994-E1D3-4235-81C1-246E79EC9270 Q30368944-3FD7B76F-E2FB-4102-9466-CC9B707A35EE Q30601198-E46DD6E4-B7AE-45C1-840C-7772AEEABB73 Q33784193-158EF19F-175B-4E85-B851-DE2E73AE848B Q33920996-1E7AFCDF-F477-4D4E-8003-F29C0D8ED4D2 Q34095081-E1B283C7-9BD4-4C17-B4A5-B00B95141EF2 Q34116761-5370D228-F326-4DA4-B3D0-515E8041B365 Q34414372-7A8C50E4-4917-4B60-BE2C-2A4843426EFC Q34545007-07B98A04-995A-49E0-8562-D651EEB76D50 Q34582334-305CE397-F6DC-49EE-B9A3-844C7B93F5D3 Q34655802-9FF2C17D-16C7-4DC4-9949-3BD92D3C57CD Q34718182-A1864A78-DA53-4856-9F31-697E333955B0 Q35122796-3E77DE4F-0645-49D9-AF7E-B7ECA0754BF4 Q35228889-A7FCDFE4-9B62-4358-96AF-C32065C81A8E Q35566714-61B277C5-567F-4FD9-BE8D-569115E1E147 Q35582616-5D5A6D76-8989-4EB6-AB58-7C0B5D158A8A Q35907965-AF36FBE7-0540-4C99-A020-5B6B3151C6B4 Q36052772-BD1E22FD-EB79-48C8-BF27-9CA06E3A4D94 Q36089227-2DF45BBA-F3E0-4705-8BD8-D508C4817F7B Q36135785-29EE4B00-F44E-45FA-989C-139EBD86A9B0 Q36225837-35BEA387-6038-4467-9353-857791E2539E Q36341688-DB5F2367-DF53-449C-923B-90EC018AE6FA Q36416368-28CA9A8D-1070-4B1C-942C-B43A8249F125 Q36416372-BFFD122A-753F-4B13-8D3E-C3C6866545D6 Q36426806-0C17E147-13AA-46A0-9792-63E257A1892A Q36426811-97BC35A7-C739-4638-ADAD-FCD5BFF09CCB Q36426831-1FA45D8D-0CB9-488B-B9B3-DC3F7417357A Q36431793-7F8781C3-CAAA-4F7C-B2F4-ED86CB3CE8C1 Q36431832-DBEBCB04-C8AB-4647-9AE3-594E36B66B0C

P2860

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

http://www.wikidata.org/entity/Q37373710

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 September 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Endocannabinoids acting at can ...... ular function in hypertension.

@en

Endocannabinoids acting at can ...... ular function in hypertension.

@nl

type

label

Endocannabinoids acting at can ...... ular function in hypertension.

@en

Endocannabinoids acting at can ...... ular function in hypertension.

@nl

prefLabel

Endocannabinoids acting at can ...... ular function in hypertension.

@en

Endocannabinoids acting at can ...... ular function in hypertension.

@nl

P1433

Q37373710-5763ED15-C5C0-4D4A-9C89-E016C3B13D6A

P1476

Q37373710-9821946B-B65B-4C52-B7E5-950F8BD2C055

P2093

Q37373710-0524C0A0-8C72-4B91-BDFA-D50868FCFA73

Q37373710-217B4B2B-44FD-408C-8594-314CDF531B00

Q37373710-40140C1A-C207-466C-AB60-55F94BFDAC5F

Q37373710-460842C7-74FE-4653-BA6E-08CE4D0779C0

Q37373710-7BADD975-77A4-46B1-AC2D-29BBB072A994

Q37373710-C12247CF-71E5-4DBA-A016-D38E31374B90

Q37373710-C1AE8899-7A4B-4256-96E9-E7DC5D60AD0A

Q37373710-E5C2E5AC-0A80-4CBF-94E0-65B4EBE0D598

P2860

Q37373710-041F1B39-B756-4AB1-A4D6-5D1F1A7105B5

Q37373710-06E99617-5117-4849-833A-3C2DD9F89429

Q37373710-0BFE6049-4449-4509-9150-93FAF56C4DEB

Q37373710-1A1BE8AA-72A5-4E45-B8CE-34ABB1C59F80

Q37373710-20F0AF78-7225-4BCB-9681-2A3435DC7988

Q37373710-28B73A1A-2056-416C-9189-FA2BB8951E3F

Q37373710-2F316773-FBDD-478D-90C6-AAEE8FBC1D89

Q37373710-33E54948-BD80-49E8-AE77-65C888209DD2

Q37373710-46EA40CB-4B1C-4C41-AC62-A218144A83EA

Q37373710-49F4D2AE-8C5A-4D29-ADFA-1463EC7FDD55

P304

Q37373710-D153A95A-7B2E-4932-AE56-55E724836403

P31

Q37373710-BB841ABA-3D6A-425F-8597-048E3A73478A

P356

Q37373710-AD0025DF-BEBD-4F19-A352-1084549B085F

P407

Q37373710-3D50AA6A-5163-4690-B484-29B01BA79017

P433

Q37373710-08DCD1DB-6E39-4887-84B3-E02F686C9924

P478

Q37373710-D8766D98-7B85-4723-A603-BA68F628BF11

P50

Q37373710-17792E2F-CB8A-4D7A-9C11-567FCDDBCAAC

Q37373710-9BFFEB4D-20AE-421F-8F6B-7DDAD05D1C9D

Q37373710-A5F9DB0F-0E1A-4761-826F-8B59E2AB4066

P577

Q37373710-22412D9C-CC9F-4F36-9E17-18E44CC967B7

P698

Q37373710-0579D11D-7403-4BDF-AE04-CF848F37748E

P921

Q37373710-2C36956D-3996-4F8A-BDFC-EA0700BB7804

Q37373710-371068B3-F857-4B1E-8775-1C6DA7012151

Q37373710-83b326f9-59d1-4808-8365-f3c59b89f3f4

Q37373710-C83E58FA-EDD4-438F-8697-69CD2B130165

Q37373710-E0F9C41C-66E9-4CC0-B81B-B1BE1E69E2C9

Q37373710-FC3CECB0-2223-47FA-9F7F-85CE0CC800EE

P932

Q37373710-A9FE5DF9-BD9D-46E4-BF88-7188FF424394

P356

01.CIR.0000143230.23252.D2

P1433

P1476

Endocannabinoids acting at can ...... ular function in hypertension.

@en

P2093

George Kunos

http://www.w3.org/2001/XMLSchema#string

Jie Liu

http://www.w3.org/2001/XMLSchema#string

Judith Harvey-White

http://www.w3.org/2001/XMLSchema#string

László Offertáler

http://www.w3.org/2001/XMLSchema#string

M Audrey Rudd

http://www.w3.org/2001/XMLSchema#string

Richard D Bukoski

http://www.w3.org/2001/XMLSchema#string

Svetlana Radaeva

http://www.w3.org/2001/XMLSchema#string

Sándor Bátkai

http://www.w3.org/2001/XMLSchema#string

P2860

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Molecular characterization of a peripheral receptor for cannabinoids

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension

Modulation of anxiety through blockade of anandamide hydrolysis

CB(1) receptor antagonist SR141716A inhibits Ca(2+)-induced relaxation in CB(1) receptor-deficient mice.

Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle.

Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.

P304

1996-2002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000143230.23252.D2

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Douglas Osei-Hyiaman

P577

2004-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15451779

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

arterial hypertension

cannabinoid receptor

endocannabinoids

P932

2756479

http://www.w3.org/2001/XMLSchema#string